Fibrinolytic therapy in retinal vessel occlusion;Systemische lysetherapie bei retinalen gefassverschlussen

Ophthalmologe

Volumn 95, Issue 8, 1998, Pages 568-575

  Hattenbach, Lars Olof ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Central retinal artery occlusion; Fibrinolytic therapy; Haemorrhagic retinopathy; Recombinant tissue plasminogen activator

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

CLINICAL RESEARCH; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; RETINA VEIN OCCLUSION; REVIEW; TREATMENT OUTCOME; CLINICAL TRIAL; DOSE RESPONSE; DRUG CONTRAINDICATION; FLUORESCENCE ANGIOGRAPHY; METHODOLOGY; PILOT STUDY; RETINA ARTERY OCCLUSION;

CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCEIN ANGIOGRAPHY; HUMANS; PILOT PROJECTS; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0032138123     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470050318     Document Type: Review

References (47)

1. Anderson JL, Karagounis L, Allan A, Bradford MJ, Menlove RL, Pryor TA (1991) Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. Am J Cardiol 68: 166-170
2. Ball CJ (1966) Atheromatous embolism to the brain, retina and choroid. Arch Ophthalmol 76: 690-695
3. Bertram B, Wolf S, Fisches H, Schulte K, Hoberg A, Reim M (1991) Lysebehandlung bei retinalen Arterienverschlüssen mit Plasminogen-Aktivator. Klin Monatsbl Augenheilkd 198: 295-300
4. Boljka M, Peternel P, Kolar G, Vidensek J (1984) Die thrombolytische Therapie bei Zentralgefäßverschlüssen. Klin Monatsbl Augenheilkd 185: 395-396
5. Chesebro JH, Knatterud G, Roberts R (1987) Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation 76: 142-154
6. Dollery CT, Henkind P, Paterson JW, Ramalho PS, Hill DW (1966) Focal retinal ischemia, ophthalmoscopic, circulatory and ultrastructural changes. Br J Ophthalmol 50: 285-324
7. Goldhaber SZ (1993) Alteplase versus heparin in acute pulmonary embolism: Randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341: 507-511
8. Goldhaber SZ, Meyerovitz MF, Green D (1990) Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med 88: 235-240
9. Gore JM, Sloan M, Price TR, Randall AMY, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML, and the TIMI Investigators (1991) Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study. Thrombolysis in Myocardial Infarction; Phase II, Pilot and Clinical Trial. Circulation 83: 448-459
10. Green WR, Chan CC, Hutchins GM, Terry JM (1981) Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases. Retina 1: 27-55
11. Haley EC Jr, Levy DE, Brott TG (1992) Urgent therapy for stroke. H. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 23: 641-645
12. Hansen LL, Wiek J, Wiederholt M (1989) A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 73: 895-899
13. Hattenbach LO, Scharrer I, Steinkamp GWK (1992) Fibrinolysis with low dose rt-PA in central retinal artery occlusion. Ann Hematol 64 [Suppl]
14. Hayreh SS, Weingeist TA (1980) Experimental occlusion of the central retinal artery of the retina. IV. Retinal tolerance time to acute ischaemia. Br J Ophthalmol 64: 818-825
15. Hayreh SS (1983) Classification of central retinal vein occlusion. Ophthalmology 90: 458-474
16. Hayreh SS (1983) Ocular neovascularization with retinal vascular occlusion. Ophthalmology 90: 488-506
17. Johannessen K-A, Nordrehaug JE, Lippe G von der, Vollset SE (1988) Risk factors for embolization in patients with left ventricular thrombi and acute myocardial infarction. Br Heart J 60: 104-110
18. Klien BA (1953) Occlusion of the centrat retinal vein: clinical importance of certain histopathologic observations. Am J Ophthalmol 36: 316-324
19. Kohner EM, Pettit JE, Hamilton AM (1976) Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J 1: 550-553
20. Kreutzer A, Brunner R, Schafer H-J, Sickel W, Auel H, Hossmann V (1988) Lysetherapie mit rt-PA bei Patienten mit Stamm- oder Zentralvenenocclusion der Retina. Fortschr Ophthalmol 85: 511-513
21. Kroll AJ (1968) Experimental central retinal artery occlusion. Arch Ophthalmol 79: 453-469
22. Leishman R (1957) The eye in general vascular disease: hypertension and arteriosclerosis. Br J Ophthalmol 41: 641-701
23. Leydhecker W, Krieglstein GK, Brunswig D (1978) Indikation und Grenzen der Fibrinolysetherapie bei Verschluß der Zentralarterie. Klin Monatsbl Augenheilkd 172: 43-46
24. Mach R, Kessler P, Susicky R Kubickova M (1992) Thrombolysis of arterial retinal occlusion using urokinase. Cesk Oftalmol 48: 42-47
25. Metzler de Hohmann U (1977) Fibrinolyse und Antikoagulantientherapie bei retinalen Venenverschlüssen. Med Verlagsges, Marburg/Lahn
26. Nelson ME, Talbot JF, Preston FE (1989) Recurrent multiple-branch retinal arteriolar occlusions in a patient with protein C deficiency. Graefes Arch Clin Exp Ophthalmol 227: 443-447
27. Oncel M, Peyman GA, Khoobehi B (1989) Tissue plasminogen activator in the treatment of experimental retinal vein occlusion. Retina 9: 1-7
28. Quinlan PM, Elman MJ, Bhatt AK, Mardesich P, Enger C (1990) The natural course of central retinal vein occlusion. Am J Ophthalmol 110: 118-123
29. Reim M, Bertram B, Wolf S (1988) Behandlungsversuche der Zentralvenenthrombose der Netzhaut mit Plasminogen-Aktivator (rt-PA). Klin Wochenschr 66: 143-149
30. Remky A, Wolf S, Knabben H, Schulte K, Arend O, Reim M (1993) Perifoveal capillary network in central retinal vein occlusion. Invest Ophthalmol Vis Sci 34: 840
31. Rossmann H (1973) Treatment of retinal vascular occlusion by means of fibrinolysis. Postgrad Med J [Suppl] 105-108
32. Sachers F, Guignard P (1992) Kardiales Myxom mit Zentralarterienverschluß, Hemiparese und epileptischem Anfall bei einem 9 jährigen Patienten. Klin Monatsbl Augenheilkd 201: 112-115
33. Schmidt D, Schumacher M, Wakhloo AK (1992) Microcatheter urokinase infusion in central retinal artery occlusion. Am J Ophthalmol 113: 429-434
34. Sloan M, Gore JM (1992) Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis. Am J Cardiol 69: 21A-38A
35. Smith P, Green WR, Miller NR, Terry JM (1980) Clinicopathologic case report of bilateral central retinal vein occlusion in Reye's syndrome. Arch Ophthalmol 98: 1256-1260
36. Stemkamp GW, Hattenbach LO, Scharrer I, Ohrloff C (1994) Front-loading-rt-PA Lysetherapie bei Zentral- oder Venenastverschlüssen der Netzhaut. Ophthalmologe 91: 280-282
37. The GUSTO angiographic investigators (1993) The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329: 1615-1622
38. The GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329: 673-682
39. The National Institute of Neurological Disorders and Stroke rt-PA Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587
40. The Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators (1998) A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med 338: 1105-1111
41. Tillett WS, Johnson AJ, Mc Carty WR (1955) The intravenous infusion of the strepto-coccal fibrinolytic principle (streptokinase) into patients. J Clin Invest 34: 169-185
42. Verstraete M, Bernard R, Bory M (1985) Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: report from the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator. Lancet 1: 842-847
43. Vulpius K, Höh H, Lange H, Maercker W, Rühle H (1996) Selektive perkutane transluminale Lysetherapie mit rt-PA bei retinalem Zentralarterienverschluß. Ophthalmologe 93: 149-153
44. Wiederholt M, Leonhardt H, Schmid-Schonbein H, Hager H (1980) Die Behandlung von Zentralvenenverschlüssen und Zentralarterienverschlüssen mit isovolämischer Hämodilution. Klin Monatsbl Augenheilkd 177: 157-164
45. Wolf S, Arend O, Bertram B, Remky A, Schulte K, Wald KJ, Reim M (1994) Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 232: 33-39
46. Wolf S, Arend O, Reim M (1994) Measurement of retinal hemodynamics with scanning laser ophthalmoscopy: reference values and variation. Surv Ophthalmol [Suppl] 38: 95-100
47. Zimmermann LE (1965) Embolism of the central retinal artery secondary to myocardial infarction with mural thrombosis. Arch Ophthalmol 73: 822-826